HI
BIO icon

Horizon Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Horizon Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-371
Closed -$101K – 843
2024
Q2 		$101K Sell
371
-3
-0.8% -$873 ﹤0.01% 623
2024
Q1 		$129K Sell
374
-5
-1% -$1.64K ﹤0.01% 608
2023
Q4 		$122K Buy
379
+60
+19% +$18.8K ﹤0.01% 595
2023
Q3 		$114K Buy
319
+5
+2% +$1.93K ﹤0.01% 603
2023
Q2 		$119K Sell
314
-10
-3% -$4.07K ﹤0.01% 597
2023
Q1 		$155K Buy
+324
New +$152K ﹤0.01% 563
2021
Q4 		– Sell
-420
Closed -$313K – 485
2021
Q3 		$313K Buy
+420
New +$315K 0.01% 385

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Horizon Investments's BIO Position: Q3 2024 in Review

Horizon Investments sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2024, closing a stake of 371 shares — an estimated $101K sold.

Horizon Investments first reported a position in BIO in Q3 2021 and held it in 7 quarters. The position peaked at $313K in Q3 2021. 437 funds tracked by Wall St. Rank hold BIO as of Q3 2024.

  • Horizon Investments reported no remaining Bio-Rad Laboratories Class A position as of Q3 2024 after selling out during the quarter.
  • Horizon Investments sold 371 Bio-Rad Laboratories Class A shares in Q3 2024, an estimated $101K.
  • Horizon Investments first reported a position in Bio-Rad Laboratories Class A in Q3 2021 and held it in 7 quarters.
  • Horizon Investments's Bio-Rad Laboratories Class A position peaked at $313K in Q3 2021.
  • 437 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2024.

Based on Horizon Investments's 13F filing for Q3 2024, filed 13 Nov 2024.